ATI LPN
ATI LPN Pharmacology N113 Exam Questions
Extract:
Question 1 of 5
A nurse is reinforcing teaching with a client who has a prescription for lithium carbonate to treat bipolar disorder. Which of the following instructions should the nurse include?
Correct Answer: B
Rationale: It can take up to 3 weeks to see the full effects of lithium carbonate, which is used to treat bipolar disorder.
Question 2 of 5
A nurse is reinforcing teaching with a client who has a new prescription for phenytoin. The nurse should recognize that which of the following statements by the client indicates a need for further teaching?
Correct Answer: C
Rationale: Phenytoin is typically used as a long-term treatment for seizure disorders. Stopping the medication suddenly can increase the risk of seizures and should only be done under the guidance of a healthcare provider.
Question 3 of 5
A nurse is reinforcing teaching about Rho(D) immunoglobulin to a client who is pregnant. Which of the following findings can an Rh incompatibility cause?
Correct Answer: D
Rationale: This is a severe complication of Rh incompatibility where the fetus experiences severe edema due to hemolytic anemia and heart failure. It results from the destruction of fetal red blood cells by maternal antibodies against Rh-positive blood cells.
Question 4 of 5
A nurse is reinforcing teaching with a client who takes lithium carbonate for bipolar disorder. For which of the following findings should the nurse monitor as an adverse effect of lithium carbonate?
Correct Answer: A
Rationale: Lithium can cause hypothyroidism and goiter as adverse effects.
Therefore, monitoring of thyroid function and physical examination for thyroid enlargement is necessary during lithium therapy.
Question 5 of 5
A nurse is reinforcing teaching for a client who is depressed and has a prescription for fluoxetine 20 mg PO twice daily. The nurse should identify that which of the following statements by the client demonstrates an understanding of the teaching?
Correct Answer: A
Rationale: Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), can cause changes in weight. Reporting weight changes to the healthcare provider is important for monitoring and managing potential side effects.